Teleflex reported strong Q4 2025 results, with revenue growth driven by its Urology and Vascular segments. The company highlighted the successful integration of Standard Bariatrics and provided optimistic financial guidance for the upcoming year, reflecting confidence in its strategic initiatives.
Comments